Robot Heart Bypass, No Chest Crack

Heart surgeons can now bypass blocked arteries through keyhole incisions without ever cracking open your chest — and most patients go home in two days.

Quick Take

Totally Endoscopic Coronary Artery Bypass (TECAB) is a fully robotic, closed-chest heart bypass done through small keyhole incisions — no cracked sternum required.
A study of 874 patients showed a 97% graft success rate, average hospital stay of just 2.3 days, and 93% of patients free from major heart or stroke events over nearly four years of follow-up.
A 2018 review of 3,721 TECAB patients found operative mortality of just 0.80% — results comparable to traditional bypass surgery.
The procedure works for both single and multiple blocked arteries, but only a handful of specialized centers in the U.S. currently perform it.

What TECAB Actually Does That Traditional Bypass Cannot

Traditional coronary artery bypass surgery splits the breastbone wide open. Surgeons spread the chest apart, stop the heart, and work in a large open field. Recovery takes six to twelve weeks. TECAB skips all of that. Surgeons use a robotic system — most often the da Vinci platform — and operate through three or four small cuts between the ribs. The chest stays closed. The heart often keeps beating throughout the entire procedure.

The robotic arms give surgeons a magnified, three-dimensional view inside the chest. They can sew grafts onto blocked arteries with precision that human hands alone cannot match in such a tight space. The internal thoracic artery — the gold-standard graft material — gets harvested and sewn into place entirely through those same small incisions. No bone is cut. No large scar runs down the middle of the chest.

The Numbers Behind a Decade of Real Patient Outcomes

The strongest evidence for TECAB comes from a single high-volume program that tracked 874 patients for up to ten years. Average hospital stay was 2.3 days. Hospital mortality was 0.80%. Early graft success — meaning the bypass was open and working shortly after surgery — came in at 97%, with the critical left-side artery graft hitting 98%. At nearly four years of follow-up, 93% of patients had avoided major heart attacks, strokes, or cardiac death.^[1]

A separate published review pooled 17 studies covering 3,721 TECAB patients. Operative mortality held at 0.80%. Early graft success was 94.8%. The review found no meaningful difference in death rates or stroke rates when comparing TECAB to minimally invasive bypass done through a small chest opening.^[7] These are not theoretical numbers. They reflect real patients who went home in days, not weeks.

Who Qualifies — and Who Does Not

TECAB is not for every heart patient. Surgeons at experienced centers describe it as best suited for patients with one to four blocked arteries who do not have severely calcified or diffusely diseased vessels.^[13] Patients with heavily diseased arteries throughout the heart may need a more traditional approach. The procedure also works well as part of a hybrid strategy — where the robot handles one or two bypasses and a cardiologist places stents in other vessels during a separate procedure.^[1]

About 45% of patients in the largest published series underwent this hybrid approach.^[1] That flexibility matters. It means TECAB does not have to replace all bypass surgery to be valuable. It can work alongside other tools, giving patients the least invasive option for the arteries where robotic bypass makes the most sense.

Why Most Hospitals Still Do Not Offer It

Here is the frustrating part. The results are strong. The logic is sound. Yet only a small number of U.S. centers perform TECAB today. The University of Chicago Medicine hosts a national symposium specifically to train more surgeons.^[3] Researchers who published the ten-year outcomes study called directly for more industry support and wider surgeon adoption to keep the procedure alive.^[1] That is a remarkable thing to write in a medical journal — essentially a warning that a proven technique could disappear for lack of takers.

The barriers are real. TECAB has a steep learning curve. Robotic systems are expensive. Reimbursement from insurers does not always reflect the complexity of the procedure. Research on cardiac technology adoption shows that early adoption tracks closely with hospital patient volume and operating margins — not just clinical outcomes.^[21] That means a technique can have excellent results and still struggle to spread if the economics do not line up. For patients living near one of the few centers that perform TECAB, the option exists. For most Americans, it does not — not yet.

What This Means If You or Someone You Know Needs Bypass Surgery

If a doctor recommends coronary artery bypass surgery, asking whether TECAB is an option costs nothing. Most community hospitals will say no. But a handful of major academic medical centers — including the University of Chicago Medicine and Yale Medicine — do offer it.^[4]^[9] The data supports seeking out that option when it fits the patient’s anatomy. A 2.3-day hospital stay versus a week or more, no cracked sternum, and comparable graft success rates are not small differences. For the right patient, they are life-changing ones.